Devonian Health Group, Inc.
No trades
No trades
Compare with Devonian Health Group, Inc.
−2.23 CAD
−6.01 M CAD
23.59 M CAD
2.44 M
Details
Sector
Industry
CEO
André P. Boulet
Website
Headquarters
Montmagny
Founded
2015
ISIN
CA2518348834
CUSIP
251834883
FIGI
BBG006BRCGL2
Identifiers
ISIN CA2518348834
Devonian Health Group, Inc. is a clinical-stage pharmaceutical company. The firm is engaged in the development of drugs for a range of autoimmune and fibroinflammatory conditions, using novel therapeutic approaches to address unmet medical needs. It offers therapeutic and cosmeceutical products. Its drug candidate, Thykamine product is issued from Devonian’s SUPREX platform, is a product for the prevention and treatment of health conditions related to inflammation and oxidative stress including ulcerative colitis, atopic dermatitis, psoriasis, rheumatoid arthritis, and other autoimmune disorders. The company was founded by Andre P. Boulet on March 27, 2015 and is headquartered in Montmagny, Canada.
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently asked questions
The current price of GSD is 7.75 CAD — it hasn't changed in the past 24 hours. Watch Devonian Health Group, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on TSXV exchange Devonian Health Group, Inc. stocks are traded under the ticker GSD.
GSD stock has fallen by −9.04% compared to the previous week, the month change is a 6.75% rise, over the last year Devonian Health Group, Inc. has showed a −13.89% decrease.
GSD stock is 0.00% volatile and has beta coefficient of 0.48. Track Devonian Health Group, Inc. stock price on the chart and check out the list of the most volatile stocks — is Devonian Health Group, Inc. there?
Today Devonian Health Group, Inc. has the market capitalization of 21.55 M, it has increased by 9.68% over the last week.
Yes, you can track Devonian Health Group, Inc. financials in yearly and quarterly reports right on TradingView.
GSD net income for the last quarter is −1.94 M CAD, while the quarter before that showed −2.24 M CAD of net income which accounts for 0.00% change. Track more Devonian Health Group, Inc. financial stats to get the full picture.
No, GSD doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Devonian Health Group, Inc. EBITDA is −5.98 M CAD, and current EBITDA margin is −1.80%. See more stats in Devonian Health Group, Inc. financial statements.
Like other stocks, GSD shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Devonian Health Group, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Devonian Health Group, Inc. technincal analysis shows the sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Devonian Health Group, Inc. stock shows the strong sell signal. See more of Devonian Health Group, Inc. technicals for a more comprehensive analysis.